A 13
Pill imprint A 13 has been identified as Metformin hydrochloride 850 mg.
Metformin is used in the treatment of diabetes, type 2; insulin resistance syndrome; female infertility; polycystic ovary syndrome and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy.
Metformin 850 mg is not subject to the Controlled Substances Act.
See also related documents.
Metformin hydrochloride Images
- Imprint:
-
A
13 - Strength:
- 850 mg
- Color:
- White
- Size:
- 13.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- povidone k90
magnesium stearate
hypromellose 2910 (5 mPa.s)
polyethylene glycol 400
polyethylene glycol 6000
- Drug Class:
- Non-sulfonylureas
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Aurobindo Pharma
- National Drug Code (NDC):
- 65862-0009
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00185-0215 | Eon Labs Inc |
| 64679-0529 | Wockhardt USA |
| 62584-0332 | Amerisource Health Services |
| 59762-4321 | Greenstone LLC |
| 54569-5353 | A S Medication Solutions LLC (repackager) |
| 49999-0495 | Lake Erie Medical and Surgical Supply (repackager) |
| 23490-6839 | Palmetto State Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Metformin Hydrochloride resources
- Metformin
- Metformin (Wolters Kluwer)
- Metformin Extended-Release Tablets (Wolters Kluwer)
- Metformin Solution (Wolters Kluwer)
- metformin (Cerner Multum)
- metformin (Micromedex) - Includes Dosage Information
- Metformin Hydrochloride (AHFS DI)
- Metformin (FDA)
- Metformin Extended Release (FDA)
- Metformin Hydrochloride (Wolters Kluwer)
Search Again
